FENFLURAMINE Side Effects

6083185-3 | Blood Pressure Immeasurable, Dyspnoea, Fatigue, Oedema Peripheral
on Feb 13, 2009 Female patient from UNITED STATES , 47 years of age, weighting 199.0 lb, was treated with Fenfluramine (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure immeasurable, dyspnoea, fatigue, oedema peripheral. Fenfluramine dosage: Oral. During the same period patient was treated with FASTIN (Oral) (View Fastin Review and Fastin Label ).

5444533-8 | Pulmonary Hypertension
Patient was taking Fenfluramine (View Usage). Patient had the following side effects: pulmonary hypertension (What is pulmonary hypertension?) on Sep 04, 2007 from UNITED STATES Additional patient health information: Female patient , 50 years of age, was diagnosed with weight decreased and. Fenfluramine dosage: Po 8-9 Months. During the same period patient was treated with PHENTERMINE (Po 8-9 Months) (View Phentermine Review and Phentermine Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), SUCRALAFATE (View Sucralafate Review and Sucralafate Label ), ATROVASTATIN (View Atrovastatin Review and Atrovastatin Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), BUDESONIDE (View Budesonide Review and Budesonide Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

4999298-0 | Pulmonary Hypertension, Raynaud's Phenomenon
Adverse event was reported on May 09, 2006 by a Female patient taking Fenfluramine (View Usage) (Dosage: Daily Po) was diagnosed with obesity (What is obesity?), weight control (What is weight control?) and. Location: UNITED STATES , 65 years of age, weighting 220.0 lb, After Fenfluramine was administered, patient had the following side effects: pulmonary hypertension (What is pulmonary hypertension?), raynaud's phenomenon. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), FENOFEXADINE (View Fenofexadine Review and Fenofexadine Label ), PAROXETINE (View Paroxetine Review and Paroxetine Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

4821660-7 | Amnesia, Chronic Fatigue Syndrome, Fibromyalgia, Insomnia, Neurotoxicity, Neurotransmitter Level Altered
on Nov 03, 2005 Female patient from UNITED STATES , 38 years of age, weighting 138.0 lb, was diagnosed with weight control (What is weight control?) and was treated with Fenfluramine (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, chronic fatigue syndrome (What is chronic fatigue syndrome?), fibromyalgia, insomnia, neurotoxicity, neurotransmitter level altered. Fenfluramine dosage: . During the same period patient was treated with PHENTERMINE (View Phentermine Review and Phentermine Label ).


4731360-X | Pulmonary Hypertension
on Aug 01, 2005 Female patient from UNITED STATES , 35 years of age, weighting 297.6 lb, was diagnosed with obesity (What is obesity?) and was treated with Fenfluramine (View Usage). Patient had the following side effects: pulmonary hypertension (What is pulmonary hypertension?). Fenfluramine dosage: Oral. During the same period patient was treated with PHENTERMINE (View Phentermine Review and Phentermine Label ). Patient was hospitalized and became disabled.